Tìm kiếm
Tonix Pharmaceuticals Holding Corp
TNXPThêm vào danh sách theo dõi
11.870USD
-0.410-3.34%
Đóng cửa 09-11 16:00（ET）
198.99MVốn hóa
LỗP/E TTM
Thêm thông tin về Tonix Pharmaceuticals Holding Corp Công ty
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical company focused on developing and commercializing therapeutics to treat and vaccines to prevent, disease and alleviate suffering. Its development portfolio is focused on central nervous system (CNS) disorders. Its product candidates include TNX-102 SL, TNX-1300, TNX-2900, TNX-1900, TNX-1500, TNX-801, TNX-1800, TNX-4200, and TNX-1700. TNX-102 SL is for the management of fibromyalgia. Its CNS portfolio includes TNX-1300 (cocaine esterase), a biologic designed to treat cocaine intoxication that has a therapy designation. Its immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. It markets Zembrace SymTouch (sumatriptan injection) 3 mg and Tosymra (sumatriptan nasal spray) 10 mg.
Tonix Pharmaceuticals Holding Corp Hồ sơ
Mã chứng khoánTNXP
Tên công tyTonix Pharmaceuticals Holding Corp
Ngày IPOMar 29, 2010
Giám đốc điều hànhLederman (Seth)
Số lượng nhân viên81
Loại chứng khoánOrdinary Share
Kết thúc năm tài chínhMar 29
Địa chỉ26 Main Street, Suite 101
Thành phốCHATHAM
Sàn giao dịch chứng khoánNASDAQ OMX - NASDAQ BASIC
Quốc giaUnited States of America
Mã bưu điện07928
Điện thoại12129809155
Trang webhttps://www.tonixpharma.com/
Mã chứng khoánTNXP
Ngày IPOMar 29, 2010
Giám đốc điều hànhLederman (Seth)
Lãnh đạo công ty của Tonix Pharmaceuticals Holding Corp
Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Dr. Seth Lederman, M.D.
Dr. Seth Lederman, M.D.
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
24.01K
+20.83%
Dr. Seth Lederman, M.D.
Dr. Seth Lederman, M.D.
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
24.01K
+20.83%
Dr. Seth Lederman, M.D.
Dr. Seth Lederman, M.D.
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
24.01K
+20.83%
Mr. Bradley Saenger, CPA
Mr. Bradley Saenger, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
2.15K
+67.46%
Mr. Bradley Saenger, CPA
Mr. Bradley Saenger, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
2.15K
+67.46%
Mr. Bradley Saenger, CPA
Mr. Bradley Saenger, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
2.15K
+67.46%
Mr. James Treco
Mr. James Treco
Lead Independent Director
Lead Independent Director
250.00
--
Mr. James Treco
Mr. James Treco
Lead Independent Director
Lead Independent Director
250.00
--
Mr. James Treco
Mr. James Treco
Lead Independent Director
Lead Independent Director
250.00
--
Dr. Gregory M. (Greg) Sullivan, M.D.
Dr. Gregory M. (Greg) Sullivan, M.D.
Secretary
Secretary
--
--
Xem thêm
Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Dr. Seth Lederman, M.D.
Dr. Seth Lederman, M.D.
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
24.01K
+20.83%
Dr. Seth Lederman, M.D.
Dr. Seth Lederman, M.D.
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
24.01K
+20.83%
Dr. Seth Lederman, M.D.
Dr. Seth Lederman, M.D.
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
24.01K
+20.83%
Mr. Bradley Saenger, CPA
Mr. Bradley Saenger, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
2.15K
+67.46%
Mr. Bradley Saenger, CPA
Mr. Bradley Saenger, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
2.15K
+67.46%
Mr. Bradley Saenger, CPA
Mr. Bradley Saenger, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
2.15K
+67.46%
Câu hỏi thường gặp
Ai là năm cổ đông lớn nhất của Tonix Pharmaceuticals Holding Corp?
Năm cổ đông hàng đầu của Tonix Pharmaceuticals Holding Corp là: Dr. Seth Lederman, M.D.
Có bao nhiêu tổ chức nắm giữ cổ phiếu của Tonix Pharmaceuticals Holding Corp (TNXP)?
Tính đến ngày 2026Q1, có 177 tổ chức nắm giữ cổ phiếu của Tonix Pharmaceuticals Holding Corp, với tổng giá trị thị trường khoảng 4.66M, chiếm 32.65% tổng số cổ phiếu. So với ngày 2025Q4, tỷ lệ cổ phần của các tổ chức đã tăng thêm 2019652.00.